Prenatal Magnesium Sulfate and Functional Connectivity in Offspring at Term-Equivalent Age

Show simple item record

dc.contributor.author Ufkes, Steven
dc.contributor.author Kennedy, Eleanor
dc.contributor.author Poppe, Tanya
dc.contributor.author Miller, Steven P
dc.contributor.author Thompson, Benjamin
dc.contributor.author Guo, Jessie
dc.contributor.author Harding, Jane E
dc.contributor.author Crowther, Caroline A
dc.coverage.spatial United States
dc.date.accessioned 2024-07-09T02:28:44Z
dc.date.available 2024-07-09T02:28:44Z
dc.date.issued 2024-05-01
dc.identifier.citation (2024). JAMA network open, 7(5), e2413508-.
dc.identifier.issn 2574-3805
dc.identifier.uri https://hdl.handle.net/2292/69008
dc.description.abstract IMPORTANCE: Understanding the effect of antenatal magnesium sulfate (MgSO4) treatment on functional connectivity will help elucidate the mechanism by which it reduces the risk of cerebral palsy and death. OBJECTIVE: To determine whether MgSO4 administered to women at risk of imminent preterm birth at a gestational age between 30 and 34 weeks is associated with increased functional connectivity and measures of functional segregation and integration in infants at term-equivalent age, possibly reflecting a protective mechanism of MgSO4. DESIGN, SETTING, AND PARTICIPANTS: This cohort study was nested within a randomized placebo-controlled trial performed across 24 tertiary maternity hospitals. Participants included infants born to women at risk of imminent preterm birth at a gestational age between 30 and 34 weeks who participated in the MAGENTA (Magnesium Sulphate at 30 to 34 Weeks' Gestational Age) trial and underwent magnetic resonance imaging (MRI) at term-equivalent age. Ineligibility criteria included illness precluding MRI, congenital or genetic disorders likely to affect brain structure, and living more than 1 hour from the MRI center. One hundred and fourteen of 159 eligible infants were excluded due to incomplete or motion-corrupted MRI. Recruitment occurred between October 22, 2014, and October 25, 2017. Participants were followed up to 2 years of age. Analysis was performed from February 1, 2021, to February 27, 2024. Observers were blind to patient groupings during data collection and processing. EXPOSURES: Women received 4 g of MgSO4 or isotonic sodium chloride solution given intravenously over 30 minutes. MAIN OUTCOMES AND MEASURES: Prior to data collection, it was hypothesized that infants who were exposed to MgSO4 would show enhanced functional connectivity compared with infants who were not exposed. RESULTS: A total of 45 infants were included in the analysis: 24 receiving MgSO4 treatment and 21 receiving placebo; 23 (51.1%) were female and 22 (48.9%) were male; and the median gestational age at scan was 40.0 (IQR, 39.1-41.1) weeks. Treatment with MgSO4 was associated with greater voxelwise functional connectivity in the temporal and occipital lobes and deep gray matter structures and with significantly greater clustering coefficients (Hedge g, 0.47 [95% CI, -0.13 to 1.07]), transitivity (Hedge g, 0.51 [95% CI, -0.10 to 1.11]), local efficiency (Hedge g, 0.40 [95% CI, -0.20 to 0.99]), and global efficiency (Hedge g, 0.31 [95% CI, -0.29 to 0.90]), representing enhanced functional segregation and integration. CONCLUSIONS AND RELEVANCE: In this cohort study, infants exposed to MgSO4 had greater voxelwise functional connectivity and functional segregation, consistent with increased brain maturation. Enhanced functional connectivity is a possible mechanism by which MgSO4 protects against cerebral palsy and death.
dc.language eng
dc.publisher American Medical Association (AMA)
dc.relation.ispartofseries JAMA Netw Open
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher.
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm
dc.rights.uri https://jamanetwork.com/pages/cc-by-license-permissions
dc.subject Humans
dc.subject Magnesium Sulfate
dc.subject Female
dc.subject Pregnancy
dc.subject Infant, Newborn
dc.subject Magnetic Resonance Imaging
dc.subject Male
dc.subject Adult
dc.subject Gestational Age
dc.subject Cohort Studies
dc.subject Premature Birth
dc.subject Infant
dc.subject Brain
dc.subject Prenatal Care
dc.subject Cerebral Palsy
dc.subject 3213 Paediatrics
dc.subject 3215 Reproductive Medicine
dc.subject 32 Biomedical and Clinical Sciences
dc.subject Infant Mortality
dc.subject Clinical Trials and Supportive Activities
dc.subject Preterm, Low Birth Weight and Health of the Newborn
dc.subject Clinical Research
dc.subject Prevention
dc.subject Neurosciences
dc.subject Brain Disorders
dc.subject Pediatric
dc.subject Biomedical Imaging
dc.subject Perinatal Period - Conditions Originating in Perinatal Period
dc.subject 6.1 Pharmaceuticals
dc.subject 6 Evaluation of treatments and therapeutic interventions
dc.subject Reproductive health and childbirth
dc.subject 42 Health sciences
dc.title Prenatal Magnesium Sulfate and Functional Connectivity in Offspring at Term-Equivalent Age
dc.type Journal Article
dc.identifier.doi 10.1001/jamanetworkopen.2024.13508
pubs.issue 5
pubs.begin-page e2413508
pubs.volume 7
dc.date.updated 2024-06-05T10:36:18Z
dc.rights.holder Copyright: The authors en
pubs.author-url https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2819063
pubs.publication-status Published online
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Journal Article
pubs.subtype Randomized Controlled Trial
pubs.elements-id 1029990
pubs.org-id Liggins Institute
pubs.org-id LiFePATH
dc.identifier.eissn 2574-3805
dc.identifier.pii 2819063
pubs.record-created-at-source-date 2024-06-05
pubs.online-publication-date 2024-05-28


Files in this item

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Browse

Statistics